Indian pharmaceutical firm Ranbaxy has launched the drug Synriam, which it claims will prove a more efficient and simpler treatment for malaria. It is the first recently developed antimalarial that is not based on artemisinin, one of the most effective treatments for malaria, which has begun to suffer from problems with resistance in recent years. Ranbaxy has hailed Synriam as India's first domestically developed drug - although none of its active ingredients were discovered in the country. Arterolane was discovered by a collaborative drug discovery project funded by the Medicines for Malaria Venture Ranbaxy developed Synriam as a fixed-dose combination...
